Andorra vs Kazakhstan: Immunization, Hib3
Andorra
98.0%
in 2024
Kazakhstan
98.0%
in 2024
Andorra rank
20th
Kazakhstan rank
20th
Immunization, Hib3 over time
- Andorra
- Kazakhstan
How they compare
Andorra currently reports 98.0% against 98.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 9 times across 17 shared years of data; in 2008 it was Andorra ahead.
Andorra ranks 20th and Kazakhstan ranks 20th of 191 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.5% | 73.0% | 24.5% | Andorra |
| 2010s | 97.9% | 95.6% | 2.3% | Andorra |
| 2020s | 97.6% | 95.8% | 1.8% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Andorra or Kazakhstan?
- Andorra, at 98.0% against 98.0% in Kazakhstan as of 2024.
- What is the difference in immunization, hib3 between Andorra and Kazakhstan?
- 0.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Kazakhstan?
- 17 years are reported by both, from 2008 to 2024.
- How do Andorra and Kazakhstan rank globally for immunization, hib3?
- Andorra ranks 20th and Kazakhstan ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.